BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4359343)

  • 1. Clinical evaluation of the luteinizing hormone-releasing hormone (LH-RH) test in cases with anatomically verified disorders of the hypothalamo-pituitary region.
    Lundberg PO
    Acta Neurol Scand; 1973; 49(4):461-72. PubMed ID: 4359343
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between leuteinizing hormone responses to luteinizing hormone-releasing hormone (LH-RH) and to D-leu-6-LH-RH-ethylamide in patients with hypothalamo-pituitary disease.
    Guitelman A; Mancini A; Vargas C; Rozados R; Dujovne A; Lebas C; Aparicio NJ; Coy DH; Schally AV
    Fertil Steril; 1976 Oct; 27(10):1154-7. PubMed ID: 183989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical endocrine investigations in patients with pituitary adenoma (author's transl)].
    Mühlenstedt D; Hanker J; Schneider HP
    Arch Gynakol; 1978 Jul; 225(3):237-45. PubMed ID: 209760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Symptoms of tumors in the region of the optic chiasm and their practical significance].
    Kühl W; Sellentin W
    Z Arztl Fortbild (Jena); 1968 Jun; 62(12):640-5. PubMed ID: 4300610
    [No Abstract]   [Full Text] [Related]  

  • 5. TRF test in patients with hypothalamic-pituitary disorders.
    Otsuki M; Tateiwa M; Baba S
    Endocrinol Jpn; 1973 Apr; 20(2):149-55. PubMed ID: 4198533
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of intravenous injection of synthetic TRH in hypophyseal pathology].
    Jaquet P; Codaccioni JL; Oliver C; Vague P; Carlon N; Vague J
    Ann Endocrinol (Paris); 1972; 33(4):331-9. PubMed ID: 4351891
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnostic procedures in diencephalo-hypophyseal insufficiency (author's transl)].
    Solbach HG; Wiegelmann W; Kley HK; Rudorff KH; Krüskemper HL
    Klin Wochenschr; 1979 May; 57(10):487-97. PubMed ID: 459366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response to TRH, LH-RH, metyrapone and vasopressin in patients with hypothalamo-pituitary disorders.
    Lundberg PO; Wide L
    Eur J Clin Invest; 1973 Jan; 3(1):49-56. PubMed ID: 4347096
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypothalamo-pituitary-adrenal function in pituitary adenoma and craniopharyngioma. Part I: Insulin test, lysine-vasopressin test, and rapid ACTH test.
    Takeuchi J; Sugimoto T; Yoshimi T; Nanno M; Handa H
    Surg Neurol; 1977 Dec; 8(6):423-7. PubMed ID: 202036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of synthetic LRF and TRF in a combined function test in patients with pituitary tumors.
    zur Mühlen A von ; Köbberling J; Halves E; Scharphuis T
    Acta Endocrinol Suppl (Copenh); 1973; 173():94. PubMed ID: 4199196
    [No Abstract]   [Full Text] [Related]  

  • 11. [The diagnostic significance of synthetic LH-RH (luteinizing hormone-releasing hormone) in evaluating gonadotropic pituitary function (author's transl)].
    Solbach HG; Wiegelmann W; Kley HK; Zimmermann H; Krüskemper HL
    Dtsch Med Wochenschr; 1973 Nov; 98(45):2114-9. PubMed ID: 4585937
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypothalamo-pituitary-adrenal function in pituitary adenoma and craniopharyngioma. Part II: insulin test and clinical features.
    Takeuchi J; Naruo Y; Yoshimi T; Nanno M; Handa H
    Surg Neurol; 1977 Dec; 8(6):428-30. PubMed ID: 304253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On differential diagnosis of sellar and parasellar tumors].
    Kalberer M
    Med Welt; 1967 May; 21():1305-11. PubMed ID: 4305343
    [No Abstract]   [Full Text] [Related]  

  • 14. [Secondary anemorrhea in processes in the sella region].
    Synowitz HJ; Siedschiag WD
    Zentralbl Gynakol; 1975; 97(11):656-60. PubMed ID: 171883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Central scotomas in sellar and suprasellar tumors].
    Kawabata H; Uchida H; Harada K
    Nihon Ganka Kiyo; 1968 Sep; 19(9):937-43. PubMed ID: 4303972
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of gonadotropin releasing hormone on pituitary gonadotropin function in the presence of neoplasms of the pituitary gland].
    Perria C; Rolandi E; Masturzo P; Capitanio GL; Indiveri F; Polleri A
    Boll Soc Ital Biol Sper; 1974 Apr; 50(7):424-9. PubMed ID: 4374222
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of the LH-RH test in the evaluation of pituitary gonadotropic function].
    Antaki A; Chapdelaine A; Van Campenhout J; Rochefort JG
    Union Med Can; 1974 Jul; 103(7):1191-201. PubMed ID: 4601776
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study of the thyrotropin-releasing factor (TRF) test. II. TRF test in hypothalamo-pituitary disorders].
    Sakoda M; Otsuki M; Mori H; Baba S; Hiroshige N
    Nihon Naibunpi Gakkai Zasshi; 1972 May; 48(2):90-100. PubMed ID: 4627254
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endocrinological diagnosis of pituitary tumors].
    Nieshlag E; Kroeger FJ; Wombacher H; Overzier C
    Dtsch Med Wochenschr; 1971 Jan; 96(1):46-7. PubMed ID: 4321490
    [No Abstract]   [Full Text] [Related]  

  • 20. The usefulness of thyrotropin-releasing factor (TRF) test in patients with hypothalamic-pituitary disorders.
    Otsuki M; Tateiwa M; Mori H; Baba S
    Kobe J Med Sci; 1973 Mar; 19(1):13-22. PubMed ID: 4202733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.